InsiderSignal.AI

InsiderSignal.ai

KLRA - Kailera Therapeutics, Inc.

Insider Purchase by Bain Capital Life Sciences Investors, LLC (10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

Yesterday, Bain Capital Life Sciences Investors, LLC, serving as 10% owner at Kailera Therapeutics, Inc. (KLRA), purchased 1,562,500 shares at $16.00 per share, for a total transaction value of $25,000,000.00. Following this transaction, Bain Capital Life Sciences Investors, LLC now holds 22,583,268 shares of KLRA.

This purchase represents a 7.00% increase in Bain Capital Life Sciences Investors, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, April 20, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 20, 2026, meaning the disclosure happened on the same day as the trade.

Kailera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Bain Capital Life Sciences Investors, LLC

10%

Bain Capital Life Sciences Investors, LLC is a Delaware-incorporated investment firm and a key entity within the Bain Capital Life Sciences platform, focused on life sciences investing.[[1]](https://www.baincapitallifesciences.com/about)[[4]](https://www.sec.gov/Archives/edgar/data/1464521/000095017025107981/0000950170-25-107981-index.htm) It recently reported beneficial ownership changes in HeartFlow, Inc. (HTFL), holding a significant 10% stake as a corporate insider, with its business address at 200 Clarendon Street, Boston, MA.[[4]](https://www.sec.gov/Archives/edgar/data/1464521/000095017025107981/0000950170-25-107981-index.htm)[[6]](https://fintel.io/i/bain-capital-life-sciences-investors) Bain Capital Life Sciences, on which this Investors entity operates, was founded in 2016, building on Bain Capital's four decades of experience in healthcare and life sciences across private equity, public equity, credit, venture capital, and real estate.[[1]](https://www.baincapitallifesciences.com/about)[[5]](https://www.baincapital.com/about-us) The firm invests globally in biopharmaceutical, medical device, diagnostic, and life science tool companies, targeting inflection capital, growth capital, fallen angels, and larger private equity collaborations, with over $7.4 billion in assets under management as of September 30, 2025.[[1]](https://www.baincapitallifesciences.com/about)[[2]](https://www.baincapitallifesciences.com) Its team combines deep industry expertise, clinical insights, and cross-asset investing experience from the broader Bain Capital platform, founded in 1984.[[2]](https://www.baincapitallifesciences.com)[[5]](https://www.baincapital.com/about-us)

View full insider profile →

Trade Price

$16.00

Quantity

1,562,500

Total Value

$25,000,000.00

Shares Owned

22,583,268

Trade Date

Monday, April 20, 2026

1 days ago

SEC Filing Date

Monday, April 20, 2026

HEALTHCAREBIOTECHNOLOGY

About Kailera Therapeutics, Inc.

Company Overview

No company information available
View news mentioning KLRA

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5808344

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime